✦ LIBER ✦

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ Scribed by J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. Harrington; Marc J. Schweiger; John A. Bittl; Kathy Wolski; Eric J. Topol; A. Michael Lincoff

Book ID: 116190389
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 179 KB
Volume: 152
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2005.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Bivalirudin During Percutaneous C

Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial

✍ Hitinder S. Gurm; Ian J. Sarembock; Dean J. Kereiakes; John J. Young; Robert A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Ischemic and bleeding outcomes in women

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ Matthews Chacko; A. Michael Lincoff; Katherine E. Wolski; David J. Cohen; John A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Outcomes of patients with acute coronary

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

✍ Vivek Rajagopal; A. Michael Lincoff; David J. Cohen; Hitinder S. Gurm; Tingfei H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 113 KB